annual CAPEX:
$141.47M-$35.27M(-19.96%)Summary
- As of today (May 29, 2025), ARWR annual capital expenditures is $141.47 million, with the most recent change of -$35.27 million (-19.96%) on September 30, 2024.
- During the last 3 years, ARWR annual CAPEX has risen by +$117.90 million (+500.28%).
- ARWR annual CAPEX is now -19.96% below its all-time high of $176.74 million, reached on September 30, 2023.
Performance
ARWR CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
$5.30M-$2.22M(-29.52%)Summary
- As of today (May 29, 2025), ARWR quarterly capital expenditures is $5.30 million, with the most recent change of -$2.22 million (-29.52%) on March 31, 2025.
- Over the past year, ARWR quarterly CAPEX has dropped by -$28.78 million (-84.45%).
- ARWR quarterly CAPEX is now -92.28% below its all-time high of $68.66 million, reached on December 31, 2023.
Performance
ARWR quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$51.55M-$28.78M(-35.83%)Summary
- As of today (May 29, 2025), ARWR TTM capital expenditures is $51.55 million, with the most recent change of -$28.78 million (-35.83%) on March 31, 2025.
- Over the past year, ARWR TTM CAPEX has dropped by -$161.69 million (-75.83%).
- ARWR TTM CAPEX is now -75.83% below its all-time high of $213.24 million, reached on March 31, 2024.
Performance
ARWR TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ARWR CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -20.0% | -84.5% | -75.8% |
| 3 y3 years | +500.3% | +11.5% | +127.5% |
| 5 y5 years | +1078.8% | +46.8% | +171.6% |
ARWR CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -20.0% | +500.3% | -92.3% | +11.5% | -75.8% | +127.5% |
| 5 y | 5-year | -20.0% | +1083.6% | -92.3% | +181.0% | -75.8% | +333.1% |
| alltime | all time | -20.0% | >+9999.0% | -92.3% | >+9999.0% | -75.8% | >+9999.0% |
ARWR CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $5.30M(-29.5%) | $51.55M(-35.8%) |
| Dec 2024 | - | $7.52M(-69.1%) | $80.33M(-43.2%) |
| Sep 2024 | $141.47M(-20.0%) | $24.29M(+68.1%) | $141.47M(-21.9%) |
| Jun 2024 | - | $14.45M(-57.6%) | $181.09M(-15.1%) |
| Mar 2024 | - | $34.08M(-50.4%) | $213.24M(+3.3%) |
| Dec 2023 | - | $68.66M(+7.4%) | $206.48M(+16.8%) |
| Sep 2023 | $176.74M(+234.9%) | $63.91M(+37.1%) | $176.74M(+21.4%) |
| Jun 2023 | - | $46.60M(+70.6%) | $145.54M(+34.2%) |
| Mar 2023 | - | $27.31M(-29.8%) | $108.47M(+26.3%) |
| Dec 2022 | - | $38.91M(+19.0%) | $85.91M(+62.8%) |
| Sep 2022 | $52.78M(+123.9%) | $32.71M(+243.0%) | $52.78M(+86.7%) |
| Jun 2022 | - | $9.54M(+100.7%) | $28.27M(+24.7%) |
| Mar 2022 | - | $4.75M(-17.8%) | $22.66M(-9.6%) |
| Dec 2021 | - | $5.78M(-29.5%) | $25.07M(+6.4%) |
| Sep 2021 | $23.57M(+97.2%) | $8.20M(+108.6%) | $23.57M(+36.6%) |
| Jun 2021 | - | $3.93M(-45.1%) | $17.25M(+11.6%) |
| Mar 2021 | - | $7.17M(+67.8%) | $15.46M(+29.9%) |
| Dec 2020 | - | $4.27M(+126.6%) | $11.90M(-0.4%) |
| Sep 2020 | $11.95M(-0.4%) | $1.89M(-11.8%) | $11.95M(-33.2%) |
| Jun 2020 | - | $2.14M(-40.8%) | $17.90M(-5.7%) |
| Mar 2020 | - | $3.61M(-16.5%) | $18.98M(+21.8%) |
| Dec 2019 | - | $4.32M(-44.8%) | $15.58M(+29.9%) |
| Sep 2019 | $12.00M(+744.4%) | $7.83M(+142.9%) | $12.00M(+145.9%) |
| Jun 2019 | - | $3.22M(+1440.1%) | $4.88M(+163.1%) |
| Mar 2019 | - | $209.30K(-71.6%) | $1.85M(-8.4%) |
| Dec 2018 | - | $737.50K(+3.9%) | $2.02M(+42.4%) |
| Sep 2018 | $1.42M(-82.1%) | $709.50K(+258.2%) | $1.42M(+73.5%) |
| Jun 2018 | - | $198.10K(-47.6%) | $819.20K(-53.9%) |
| Mar 2018 | - | $378.30K(+179.4%) | $1.78M(-35.5%) |
| Dec 2017 | - | $135.40K(+26.1%) | $2.76M(-65.2%) |
| Sep 2017 | $7.92M(+105.1%) | $107.40K(-90.7%) | $7.92M(-24.8%) |
| Jun 2017 | - | $1.16M(-14.7%) | $10.52M(+5.1%) |
| Mar 2017 | - | $1.36M(-74.4%) | $10.01M(+14.4%) |
| Dec 2016 | - | $5.30M(+95.3%) | $8.75M(+126.7%) |
| Sep 2016 | $3.86M(+95.9%) | $2.71M(+319.2%) | $3.86M(+94.7%) |
| Jun 2016 | - | $647.10K(+588.4%) | $1.98M(+22.4%) |
| Mar 2016 | - | $94.00K(-76.9%) | $1.62M(-11.1%) |
| Dec 2015 | - | $406.60K(-51.3%) | $1.82M(-7.5%) |
| Sep 2015 | $1.97M(+14.7%) | $835.00K(+194.4%) | $1.97M(+23.1%) |
| Jun 2015 | - | $283.60K(-4.5%) | $1.60M(-18.4%) |
| Mar 2015 | - | $297.10K(-46.5%) | $1.96M(-9.0%) |
| Dec 2014 | - | $554.90K(+19.2%) | $2.16M(+25.5%) |
| Sep 2014 | $1.72M | $465.40K(-27.8%) | $1.72M(+26.5%) |
| Jun 2014 | - | $644.20K(+31.0%) | $1.36M(+55.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2014 | - | $491.60K(+323.1%) | $873.20K(+116.4%) |
| Dec 2013 | - | $116.20K(+10.5%) | $403.60K(+36.0%) |
| Sep 2013 | $296.90K(-38.1%) | $105.20K(-34.3%) | $296.80K(+6.6%) |
| Jun 2013 | - | $160.20K(+628.2%) | $278.50K(+19.1%) |
| Mar 2013 | - | $22.00K(+134.0%) | $233.90K(-44.3%) |
| Dec 2012 | - | $9400.00(-89.2%) | $419.70K(-12.5%) |
| Sep 2012 | $479.70K(+4845.4%) | $86.90K(-24.8%) | $479.70K(+22.1%) |
| Jun 2012 | - | $115.60K(-44.4%) | $392.80K(+39.8%) |
| Mar 2012 | - | $207.80K(+199.4%) | $281.00K(+255.2%) |
| Dec 2011 | - | $69.40K(>+9900.0%) | $79.10K(+715.5%) |
| Sep 2011 | $9700.00(-75.9%) | $0.00(-100.0%) | $9700.00(0.0%) |
| Jun 2011 | - | $3800.00(-35.6%) | $9700.00(+64.4%) |
| Mar 2011 | - | $5900.00(>+9900.0%) | $5900.00(-85.3%) |
| Sep 2009 | $40.20K(-94.1%) | $0.00(-100.0%) | $40.20K(-81.3%) |
| Jun 2009 | - | $12.10K(>+9900.0%) | $215.40K(-39.6%) |
| Mar 2009 | - | $0.00(-100.0%) | $356.60K(-34.5%) |
| Dec 2008 | - | $28.10K(-84.0%) | $544.50K(-20.4%) |
| Sep 2008 | $684.10K(-9.6%) | $175.20K(+14.3%) | $684.20K(-2.5%) |
| Jun 2008 | - | $153.30K(-18.4%) | $701.70K(-26.8%) |
| Mar 2008 | - | $187.90K(+12.0%) | $959.00K(+18.6%) |
| Dec 2007 | - | $167.80K(-12.9%) | $808.70K(+6.9%) |
| Sep 2007 | $756.40K(-19.1%) | $192.70K(-53.1%) | $756.50K(-13.2%) |
| Jun 2007 | - | $410.60K(+992.0%) | $871.60K(+12.8%) |
| Mar 2007 | - | $37.60K(-67.5%) | $772.60K(-19.0%) |
| Dec 2006 | - | $115.60K(-62.4%) | $953.50K(+2.0%) |
| Sep 2006 | $934.50K(+38.9%) | $307.80K(-1.2%) | $934.50K(+58.4%) |
| Jun 2006 | - | $311.60K(+42.6%) | $590.00K(+14.2%) |
| Mar 2006 | - | $218.50K(+126.2%) | $516.80K(+32.1%) |
| Dec 2005 | - | $96.60K(-363.2%) | $391.10K(-41.9%) |
| Sep 2005 | $672.80K(+1.1%) | -$36.70K(-115.4%) | $672.70K(-41.7%) |
| Jun 2005 | - | $238.40K(+156.9%) | $1.15M(+2.2%) |
| Mar 2005 | - | $92.80K(-75.5%) | $1.13M(+8.1%) |
| Dec 2004 | - | $378.20K(-14.8%) | $1.04M(+56.8%) |
| Sep 2004 | $665.50K(>+9900.0%) | $443.90K(+107.9%) | $665.50K(+200.3%) |
| Jun 2004 | - | $213.50K(+2535.8%) | $221.60K(+2635.8%) |
| Mar 2004 | - | $8100.00(>+9900.0%) | $8100.00(+376.5%) |
| Sep 2003 | $2100.00(+23.5%) | - | - |
| Sep 2002 | $1700.00(+142.9%) | $0.00(0.0%) | $1700.00(0.0%) |
| Jun 2002 | - | $0.00(-100.0%) | $1700.00(0.0%) |
| Mar 2002 | - | $1700.00(>+9900.0%) | $1700.00(+142.9%) |
| Sep 2000 | $700.00 | $0.00(0.0%) | $700.00(0.0%) |
| Jun 2000 | - | $0.00(0.0%) | $700.00(0.0%) |
| Mar 2000 | - | $0.00(-100.0%) | $700.00(0.0%) |
| Dec 1999 | - | $700.00 | $700.00 |
FAQ
- What is Arrowhead Pharmaceuticals annual capital expenditures?
- What is the all time high annual CAPEX for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals annual CAPEX year-on-year change?
- What is Arrowhead Pharmaceuticals quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals quarterly CAPEX year-on-year change?
- What is Arrowhead Pharmaceuticals TTM capital expenditures?
- What is the all time high TTM CAPEX for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals TTM CAPEX year-on-year change?
What is Arrowhead Pharmaceuticals annual capital expenditures?
The current annual CAPEX of ARWR is $141.47M
What is the all time high annual CAPEX for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high annual capital expenditures is $176.74M
What is Arrowhead Pharmaceuticals annual CAPEX year-on-year change?
Over the past year, ARWR annual capital expenditures has changed by -$35.27M (-19.96%)
What is Arrowhead Pharmaceuticals quarterly capital expenditures?
The current quarterly CAPEX of ARWR is $5.30M
What is the all time high quarterly CAPEX for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high quarterly capital expenditures is $68.66M
What is Arrowhead Pharmaceuticals quarterly CAPEX year-on-year change?
Over the past year, ARWR quarterly capital expenditures has changed by -$28.78M (-84.45%)
What is Arrowhead Pharmaceuticals TTM capital expenditures?
The current TTM CAPEX of ARWR is $51.55M
What is the all time high TTM CAPEX for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high TTM capital expenditures is $213.24M
What is Arrowhead Pharmaceuticals TTM CAPEX year-on-year change?
Over the past year, ARWR TTM capital expenditures has changed by -$161.69M (-75.83%)